290 related articles for article (PubMed ID: 26410072)
1. Down-regulation of B cell-related genes in peripheral blood leukocytes of Parkinson's disease patients with and without GBA mutations.
Kobo H; Bar-Shira A; Dahary D; Gan-Or Z; Mirelman A; Goldstein O; Giladi N; Orr-Urtreger A
Mol Genet Metab; 2016 Feb; 117(2):179-85. PubMed ID: 26410072
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the genetic variability in Parkinson's disease from Southern Spain.
Bandrés-Ciga S; Mencacci NE; Durán R; Barrero FJ; Escamilla-Sevilla F; Morgan S; Hehir J; Vives F; Hardy J; Pittman AM
Neurobiol Aging; 2016 Jan; 37():210.e1-210.e5. PubMed ID: 26518746
[TBL] [Abstract][Full Text] [Related]
3. Autosomal dominant Parkinson's disease: Incidence of mutations in LRRK2, SNCA, VPS35 and GBA genes in Brazil.
Abreu GM; Valença DC; Campos M; da Silva CP; Pereira JS; Araujo Leite MA; Rosso AL; Nicaretta DH; Vasconcellos LF; da Silva DJ; Della Coletta MV; Dos Santos JM; Gonçalves AP; Santos-Rebouças CB; Pimentel MM
Neurosci Lett; 2016 Dec; 635():67-70. PubMed ID: 27777137
[TBL] [Abstract][Full Text] [Related]
4. Genotype-phenotype correlations between GBA mutations and Parkinson disease risk and onset.
Gan-Or Z; Giladi N; Rozovski U; Shifrin C; Rosner S; Gurevich T; Bar-Shira A; Orr-Urtreger A
Neurology; 2008 Jun; 70(24):2277-83. PubMed ID: 18434642
[TBL] [Abstract][Full Text] [Related]
5. Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.
Alcalay RN; Levy OA; Waters CC; Fahn S; Ford B; Kuo SH; Mazzoni P; Pauciulo MW; Nichols WC; Gan-Or Z; Rouleau GA; Chung WK; Wolf P; Oliva P; Keutzer J; Marder K; Zhang X
Brain; 2015 Sep; 138(Pt 9):2648-58. PubMed ID: 26117366
[TBL] [Abstract][Full Text] [Related]
6. A cognitive fMRI study in non-manifesting LRRK2 and GBA carriers.
Bregman N; Thaler A; Mirelman A; Helmich RC; Gurevich T; Orr-Urtreger A; Marder K; Bressman S; Bloem BR; Giladi N;
Brain Struct Funct; 2017 Apr; 222(3):1207-1218. PubMed ID: 27401793
[TBL] [Abstract][Full Text] [Related]
7. Variants in PSMB9 and FGR differentially affect Parkinson's disease risk in GBA and LRRK2 mutation carriers.
Shani S; Goldstein O; Gana-Weisz M; Bar-Shira A; Thaler A; Gurevich T; Mirelman A; Giladi N; Alcalay RN; Orr-Urtreger A
Parkinsonism Relat Disord; 2023 Jun; 111():105398. PubMed ID: 37116292
[TBL] [Abstract][Full Text] [Related]
8. Revisiting the non-Gaucher-GBA-E326K carrier state: Is it sufficient to increase Parkinson's disease risk?
Goldstein O; Gana-Weisz M; Cohen-Avinoam D; Shiner T; Thaler A; Cedarbaum JM; John S; Lalioti M; Gurevich T; Bar-Shira A; Mirelman A; Giladi N; Orr-Urtreger A
Mol Genet Metab; 2019 Dec; 128(4):470-475. PubMed ID: 31662221
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive LRRK2 and GBA screening in Portuguese patients with Parkinson's disease: identification of a new family with the LRRK2 p.Arg1441His mutation and novel missense variants.
Zhang L; Quadri M; Guedes LC; Coelho M; Valadas A; Mestre T; Lobo PP; Rosa MM; Simons E; Oostra BA; Ferreira JJ; Bonifati V
Parkinsonism Relat Disord; 2013 Oct; 19(10):897-900. PubMed ID: 23726462
[TBL] [Abstract][Full Text] [Related]
10. Cerebral Imaging Markers of GBA and LRRK2 Related Parkinson's Disease and Their First-Degree Unaffected Relatives.
Thaler A; Kliper E; Maidan I; Herman T; Rosenberg-Katz K; Bregman N; Gurevich T; Shiner T; Hausdorff JM; Orr-Urtreger A; Giladi N; Mirelman A
Brain Topogr; 2018 Nov; 31(6):1029-1036. PubMed ID: 29846835
[TBL] [Abstract][Full Text] [Related]
11. β-Glucocerebrosidase gene mutations in two cohorts of Greek patients with sporadic Parkinson's disease.
Moraitou M; Hadjigeorgiou G; Monopolis I; Dardiotis E; Bozi M; Vassilatis D; Vilageliu L; Grinberg D; Xiromerisiou G; Stefanis L; Michelakakis H
Mol Genet Metab; 2011; 104(1-2):149-52. PubMed ID: 21745757
[TBL] [Abstract][Full Text] [Related]
12. Genetic risk factors in Finnish patients with Parkinson's disease.
Ylönen S; Siitonen A; Nalls MA; Ylikotila P; Autere J; Eerola-Rautio J; Gibbs R; Hiltunen M; Tienari PJ; Soininen H; Singleton AB; Majamaa K
Parkinsonism Relat Disord; 2017 Dec; 45():39-43. PubMed ID: 29029963
[TBL] [Abstract][Full Text] [Related]
13. Genetic assessment of familial and early-onset Parkinson's disease in a Greek population.
Bozi M; Papadimitriou D; Antonellou R; Moraitou M; Maniati M; Vassilatis DK; Papageorgiou SG; Leonardos A; Tagaris G; Malamis G; Theofilopoulos D; Kamakari S; Stamboulis E; Hadjigeorgiou GM; Athanassiadou A; Michelakakis H; Papadimitriou A; Gasser T; Stefanis L
Eur J Neurol; 2014 Jul; 21(7):963-8. PubMed ID: 24313877
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of B cell related genes in leukocytes of women with Parkinson's disease.
Kedmi M; Bar-Shira A; Gurevich T; Giladi N; Orr-Urtreger A
Mol Neurodegener; 2011 Sep; 6():66. PubMed ID: 21943286
[TBL] [Abstract][Full Text] [Related]
15. Mutations in the glucocerebrosidase gene are common in patients with Parkinson's disease from Eastern Canada.
Han F; Grimes DA; Li F; Wang T; Yu Z; Song N; Wu S; Racacho L; Bulman DE
Int J Neurosci; 2016; 126(5):415-21. PubMed ID: 26000814
[TBL] [Abstract][Full Text] [Related]
16. An assessment of the frequency of mutations in the GBA and VPS35 genes in Hungarian patients with sporadic Parkinson's disease.
Török R; Zádori D; Török N; Csility É; Vécsei L; Klivényi P
Neurosci Lett; 2016 Jan; 610():135-8. PubMed ID: 26547032
[TBL] [Abstract][Full Text] [Related]
17. Survival rates among Parkinson's disease patients who carry mutations in the LRRK2 and GBA genes.
Thaler A; Kozlovski T; Gurevich T; Bar-Shira A; Gana-Weisz M; Orr-Urtreger A; Giladi N; Mirelman A
Mov Disord; 2018 Oct; 33(10):1656-1660. PubMed ID: 30288804
[TBL] [Abstract][Full Text] [Related]
18. Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease.
Clark LN; Ross BM; Wang Y; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
Neurology; 2007 Sep; 69(12):1270-7. PubMed ID: 17875915
[TBL] [Abstract][Full Text] [Related]
19. A "dose" effect of mutations in the GBA gene on Parkinson's disease phenotype.
Thaler A; Gurevich T; Bar Shira A; Gana Weisz M; Ash E; Shiner T; Orr-Urtreger A; Giladi N; Mirelman A
Parkinsonism Relat Disord; 2017 Mar; 36():47-51. PubMed ID: 28012950
[TBL] [Abstract][Full Text] [Related]
20. Comparative Transcriptome Analysis in Monocyte-Derived Macrophages of Asymptomatic
Usenko T; Bezrukova A; Basharova K; Panteleeva A; Nikolaev M; Kopytova A; Miliukhina I; Emelyanov A; Zakharova E; Pchelina S
Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
